Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 10 Lymphoma, T-Cell, Cutaneous 10 Lymphoma, Non-Hodgkin 10 Leukemia, Lymphocytic, Chronic, B-Cell 10 Lymphoma, Mantle-Cell 9 Lymphoma, Large-Cell, Immunoblastic 9 Lymphoma, Large B-Cell, Diffuse 9 Lymphoma, Follicular 9 Lymphoma, B-Cell, Marginal Zone 9 Leukemia, Myeloid, Acute 9 Leukemia, Hairy Cell 9 Hodgkin Disease 9 Burkitt Lymphoma 9 Sezary Syndrome 8 Mycosis Fungoides 8 Leukemia, Myeloid, Chronic-Phase 7 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 7 Leukemia, Myeloid, Accelerated Phase 7 Blast Crisis 7 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6 Multiple Myeloma 6 Melanoma 6 Leukemia, Myelomonocytic, Chronic 6 Breast Neoplasms 6 Waldenstrom Macroglobulinemia 5 Primary Myelofibrosis 5 Myeloproliferative Disorders 5 Lymphoma, Large-Cell, Anaplastic 5 Lymphoma, Extranodal NK-T-Cell 5 Leukemia, Prolymphocytic 5

Interventions

HhAntag691 25 Imiquimod 12 Biopsy 12 sonidegib 11 Aminolevulinic Acid 9 cemiplimab 8 Photochemotherapy 8 Nivolumab 8 methyl 5-aminolevulinate 7 Mohs Surgery 7 1-phenyl-3,3-dimethyltriazene 7 Tomography, Optical Coherence 6 Surgical Procedures, Operative 6 Specimen Handling 5 Radiotherapy 5 Itraconazole 5 pembrolizumab 4 daromun 4 Microscopy, Confocal 4 Magnetic Resonance Spectroscopy 4 Ipilimumab 4 Curettage 4 Standard of Care 3 Niacinamide 3 IPI-926 3 CTLA-4 Antigen 3 3-ingenyl angelate 3 tazarotene 2 talimogene laherparepvec 2 relatlimab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Basal Cell × Therapeutics × Dermatologic × Clear all

NCT03610022 2026-05-19

OPTIVISMO-1

University Hospital, Bordeaux

Phase 4 Completed

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡